Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional study.

about

Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional study.

Item

http://www.wikidata.org/entity/Q40040159

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Human seroprevalence of Borrel ...... 2014: a cross-sectional study.

@en

type

Item

label

Human seroprevalence of Borrel ...... 2014: a cross-sectional study.

@en

prefLabel

Human seroprevalence of Borrel ...... 2014: a cross-sectional study.

@en

P1476

Human seroprevalence of Borrel ...... 2014: a cross-sectional study.

@en

P2093

Ainsley Gretchen

http://www.w3.org/2001/XMLSchema#string

Cecilia Dumouchel

http://www.w3.org/2001/XMLSchema#string

Janna Brancato

http://www.w3.org/2001/XMLSchema#string

Kamran Kadkhoda

http://www.w3.org/2001/XMLSchema#string

Peter J Krause

http://www.w3.org/2001/XMLSchema#string

P2860

A relapsing fever group spirochete transmitted by Ixodes scapularis ticks

Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.

Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient

Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species.

Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.

Human infections with Borrelia miyamotoi, Japan.

Large scale spatial risk and comparative prevalence of Borrelia miyamotoi and Borrelia burgdorferi sensu lato in Ixodes pacificus

Disease Risk & Landscape Attributes of Tick-Borne Borrelia Pathogens in the San Francisco Bay Area, California

Borrelia miyamotoi infection in nature and in humans.

Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia.

P304

E690-E693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.9778/CMAJO.20170070

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28882852

http://www.w3.org/2001/XMLSchema#string

P921

Seroprevalence

P932

5621960

http://www.w3.org/2001/XMLSchema#string